my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
01-06-2011: One Nucleus announced that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 January 2011.
The One Nucleus Purchasing Consortium has an annual spend of over £6 million with its 8 Preferred Suppliers and over 70 One Nucleus Gold Members. The consortium aims to utilise the buying volume of member companies to negotiate and promote Preferred Supply Agreements. The aim is not only to provide bottom line cost savings for members but to also provide added value services that would not normally be available to One Nucleus member companies on an individual basis.
Richard Dickinson, Director of Specialist Services at One Nucleus said “One Nucleus and Bionow are working together in partnership to leverage the combined buying power in a way that benefits all our member companies”.
Contact / Request information
Request further information free of charge:
Watchlist
This is where you can add this news to your personal favourites
One Nucleus signs agreement with Bionow to expand access to One Nucleus preferred suppliers
One Nucleus announced that an agreement has been signed with Bionow for their Premium Members to have access to the One Nucleus Preferred Suppliers through the One Nucleus Purchasing Consortium Scheme. This agreement took effect on 1 January 2011. The One Nucleus Purchasing Consortium has ... more
Domainex Wins Genesis Award for its Work in Supporting Translational Research
Domainex Ltd has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex’s proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and ph ... more
One Nucleus announces new director
One Nucleus announced the appointment of Dr Alan Palmer as a Director. Alan is co-founder and currently Chief Scientific Officer for MS Therapeutics Ltd and has 30 years’ experience in the biotechnology sector in roles spanning academia, research and industry. Alan has very close ties with ... more
One Nucleus is a membership organisation for international life science and healthcare companies. We are based in Cambridge and London UK, at the heart of Europe’s largest life science and healthcare cluster. Our mission is to maximise the global competitiveness of our members. Establishe ... more
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
